切换至 "中华医学电子期刊资源库"

中华眼科医学杂志(电子版) ›› 2022, Vol. 12 ›› Issue (06) : 352 -356. doi: 10.3877/cma.j.issn.2095-2007.2022.06.006

综述

永存胚胎血管的研究进展
赵超1, 郑超1, 周健1,()   
  1. 1. 710032 西安,空军军医大学西京医院眼科 全军眼科研究所
  • 收稿日期:2022-06-10 出版日期:2022-12-28
  • 通信作者: 周健
  • 基金资助:
    陕西省自然科学基础研究计划项目(2019JM-065)

Advance on the persistent fetal vasculature

Chao Zhao1, Chao Zheng1, Jian Zhou1,()   

  1. 1. Department of Ophthalmology, Eye Institute of People′s Liberation Army, Xijing Hospital, Air Force Medical University, Xi′an 710032, China
  • Received:2022-06-10 Published:2022-12-28
  • Corresponding author: Jian Zhou
引用本文:

赵超, 郑超, 周健. 永存胚胎血管的研究进展[J]. 中华眼科医学杂志(电子版), 2022, 12(06): 352-356.

Chao Zhao, Chao Zheng, Jian Zhou. Advance on the persistent fetal vasculature[J]. Chinese Journal of Ophthalmologic Medicine(Electronic Edition), 2022, 12(06): 352-356.

永存胚胎血管(PFV)是一组因眼部胚胎血管异常退化而导致的疾病,分为前部型、后部型及混合型。PFV呈散发性,95%为单眼发病,临床表现多样,并发症多且复杂,易与多种婴幼儿常患眼部疾病混淆,临床诊断难度大。目前,尚无PFV权威的指南颁布,且其在手术切口选择、后极部病变的治疗方式上尚存争议。加之,当前临床医师对PFV的认识并不充分,漏诊和误诊率高,整体预后水平差。因此,本文中笔者就PFV胚胎起源、病因、临床表现、诊断、鉴别诊断、治疗及预后的研究进展进行综述。

Persistent fetal vasculature (PFV) is a spectrum of disorders resulted from abnormal regression of ocular fetal vessels, which is classified into three types of anterior, posterior as well as combined. PFV presents sporadic with 95% of which is unilateral. The clinical manifestations of PFV are diverse with so many perplexed complications and is easily confused with other common eye diseases in infants and young children, made clinical diagnosis more difficult. There are no authoritative guidelines to guide treatment of PFV, and controversies exist in the treatment attitude of posterior pole lesions and the selection of surgical incisions. Moreover, clinicians do not know enough about PFV, resulting in a high rate of missed diagnosis and misdiagnosis, and the overall prognosis is poor. Therefore, the relevant literature on its embryonic origin and etiology, clinical manifestations, diagnosis and differential diagnosis, treatment, prognosis and basic research progress were reviewed.

图1 各类型永存胚胎血管的眼前节彩色照相和超声检查图像 图A~图C分别示前部型永存胚胎血管永存瞳孔残膜、先天性纤维血管瞳孔膜及晶状体后纤维血管膜的眼前节照相;图D示混合型永存胚胎血管的AB型超声成像
[1]
Reese AB. Persistent hyperplastic primary vitreous[J]. Am J Ophthalmol, 1955, 40(3): 317-331.
[2]
Goldberg MF. Persistent fetal vasculature (PFV): an integrated interpretation of signs and symptoms associated with persistent hyperplastic primary vitreous (PHPV)[J]. Am J Ophthalmol, 1997, 124(5): 587-626.
[3]
Solebo AL, Russell-Eggitt I, Cumberland P, et al. Congenital cataract associated with persistent fetal vasculature: findings from IoLunder2[J]. Eye (Lond), 2016, 30(9): 1204-1209.
[4]
Li Y, Li Z, Quan Y, et al. Macrophage recruitment in immune-privileged lens during capsule repair, necrotic fiber removal, and fibrosis[J]. iScience, 2021, 24(6): 102533.
[5]
Son AI, Sheleg M, Cooper MA, et al. Formation of persistent hyperplastic primary vitreous in ephrin-A5-/- mice[J]. Invest Ophthalmol Vis Sci, 2014, 55(3): 1594-1606.
[6]
Arima M, Yoshida S, Nakama T, et al. Involvement of periostin in regression of hyaloidvascular system during ocular development[J]. Invest Ophthalmol Vis Sci, 2012, 53(10): 6495-6503.
[7]
Thornton JD, Swanson DJ, Mary MN, et al. Persistent hyperplastic primary vitreous due to somatic mosaic deletion of the arf tumor suppressor[J]. Invest Ophthalmol Vis Sci, 2007, 48(2): 491-499.
[8]
Lobov IB, Rao S, Carroll TJ, et al. WNT7b mediates macro-phage-induced programmed cell death in patterning of the vasculature[J]. Nature, 2005, 437(7057): 417-421.
[9]
Wang Z, Liu CH, Huang S, et al. Assessment and characterization of hyaloid vessels in mice[J]. J Vis Exp, 2019, PMID: 31157789.
[10]
Rutland CS, Mitchell CA, Nasir M, et al. Microphthalmia, persistent hyperplastic hyaloid vasculature and lens anomalies following overexpression of VEGF-A188 from the alphaA-crystallin promoter[J]. Mol Vis, 2007, 13: 47-56.
[11]
Hahn P, Lindsten T, Tolentino M, et al. Persistent fetal ocular vasculature in mice deficient in bax and bak[J]. Arch Ophthalmol, 2005, 123(6): 797-802.
[12]
Zigler JS, Valapala M, Shang P, et al. βA3/A1-crystallin and persistent fetal vasculature (PFV) disease of the eye[J]. Biochim Biophys Acta, 2016, 1860(1): 287-298.
[13]
Maqsood H, Younus S, Fatima M, et al. Bilateral persistent hyperplastic primary vitreous: a case report and review of the literature[J]. Cureus, 2021, 13(2): e13105.
[14]
Al-Moujahed A, Callaway NF, Ludwig CA, et al. Morning glory optic nerve in Aicardi syndrome: Report of a case with fluorescein angiography[J]. Eur J Ophthalmol, 2021, 31(6): NP61-NP64.
[15]
Shastry BS. Persistent hyperplastic primary vitreous: congenital malformation of the eye[J]. Clin Exp Ophthalmol, 2009, 37(9): 884-890.
[16]
Pollard ZF. Persistent hyperplastic primary vitreous: diagnosis, treatment and results[J]. Trans Am Ophthalmol Soc, 1997, 95: 487-549.
[17]
Yeh CT, Chen KJ, Liu L, et al. Visual and anatomical outcomes with vitrectomy in posterior or combined persistent fetal vasculature in an Asian population[J]. Ophthalmic Surg Lasers Imaging Retina, 2019, 50(6): 377-384.
[18]
Kumar BR, Tripathi M, Kumari S, et al. The enigma of subnormal vision in persistent pupillary membrane[J]. Med Hypotheses, 2021, 148: 110514.
[19]
Chang M, Ancona-Lezama D, Shields CL. Vascular perfusion in persistent pupillary membrane of the iris[J]. Indian J Ophthalmol, 2019, 67(10): 1704-1705.
[20]
Lambert SR, Buckley EG, Lenhart PD, et al. Congenital fibrovascular pupillary membranes: clinical and histopathologic findings[J]. Ophthalmology, 2012, 119(3): 634-641.
[21]
Khurana S, Gupta PC, Vaiphei K, et al. A clinicopathological study of persistent fetal vasculature[J]. Indian J Ophthalmol, 2019, 67(6): 785-787.
[22]
Prakhunhungsit S, Berrocal AM. Diagnostic and Management Strategies in Patients with Persistent Fetal Vasculature: Current Insights[J]. Clin Ophthalmol, 2020, 14: 4325-4335.
[23]
Paya C, Chan H, Pechméja J, et al. Intraoperative OCT of a Mittendorf dot with persistent hyaloid artery[J]. J Fr Ophtalmol, 2016, 39(1): 109-110.
[24]
Alexandrakis G, Scott IU, Flynn HW, et al. Visual acuity outcomes with and without surgery in patients with persistent fetal vasculature[J]. Ophthalmology, 2000, 107(6): 1068-1072.
[25]
Patel M, Mukherjee D, Farsiu S, et al. Estimation of gestational age via image analysis of anterior lens capsule vascularity in preterm infants: a pilot study[J]. Front Pediatr, 2019, 7: 43.
[26]
Hu A, Pei X, Ding X, et al. Combined persistent fetal vasculature: a classification based on high-resolution B-mode ultrasound and color doppler imaging[J]. Ophthalmology, 2016, 123(1): 19-25.
[27]
赵云娥,胡曼.重视婴幼儿永存胚胎血管的诊断和治疗[J].中华眼视光学与视觉科学杂志201820(1):7-13.
[28]
Laura DM, Staropoli PC, Patel NA, et al. Widefield fluorescein angiography in the fellow eyes of patients with presumed unilateral persistent fetal vasculature[J]. Ophthalmol Retina, 2021, 5(3): 301-307.
[29]
Huang Q, Xu Y, Zhang Q, et al. Peripheral vascular abnormalities detected by fluorescein angiography in contralateral eyes of patients with persistent fetal vasculature[J]. Ophthalmic Surg Lasers Imaging Retina, 2020, 51(9): 506-511.
[30]
Hohberger B, Knorr HLJ, Mardin CY, et al. Bilateral posterior persistent hyperplastic primary vitreous [J]. Ophthalmologe, 2018, 115(8): 680-682.
[31]
Chan LT, Gole GA, Quinn GE, et al. Pathophysiology, screening and treatment of ROP: A multi-disciplinary perspective[J]. Prog Retin Eye Res, 2018, 62: 77-119.
[32]
Tauqeer Z, Yonekawa Y. Familial exudative vitreoretinopathy: pathophysiology, diagnosis, and management[J]. Asia Pac J Ophthalmol (Phila), 2018, 7(3): 176-182.
[33]
Fabian ID, Onadim Z, Karaa E, et al. The management of retinoblastoma[J]. Oncogene, 2018, 37(12): 1551-1560.
[34]
Lagrèze WA. Treatment of congenital and early childhood cataract[J]. Ophthalmologe, 2021, 118(S2): 135-144.
[35]
Aikawa Y, Baba T, Nizawa T, et al. Worsening of retinal detachment after cataract surgery in the eye with persistent fetal vasculature[J]. Case Rep Med, 2021: 6641161.
[36]
Seth NG, Kashyap H, Jurangal A, et al. Ultrasound biomicro-scopic appearance of accessory iris membrane[J]. Indian J Ophthalmol, 2019, 67(1): 122-123.
[37]
Huang YT, Lin HJ. Long term surgical outcome for persistent pupillary membranes with associated ocular abnormalities: a retrospective case series study[J]. BMC Ophthalmol, 2021, 21(1): 232.
[38]
Robb RM. Fibrous congenital iris membranes with pupillary distortion[J]. Trans Am Ophthalmol Soc, 2001, 99: 45-50.
[39]
Gavriᶊ M, Horge I, Avram E, et al. Persistent pupillary membrane or accessary iris membrane? [J]. Rom J Ophthalmol, 2015, 59(3): 184-187.
[40]
Cibis GW, Tripathi RC, Tripathi BJ. Surgical removal of congenital pupillary-iris-lens membrane[J]. Ophthalmic Surg, 1994, 25(9): 580-583.
[41]
梁天蔚,张诚玥,白大勇,等. 先天性纤维血管瞳孔膜的临床特点及治疗分析[J]. 中华眼科杂志201854(11):849-854.
[42]
Wang Q, Zhou F, Chen W, et al. A safe treatment for congenital fibrovascular pupillary membrane[J]. Eur J Ophthalmol, 2020, 30(5): 1143-1148.
[43]
Li L, Fan DB, Zhao YT, et al. Surgical treatment and visual outcomes of cataract with persistent hyperplastic primary vitreous[J]. Int J Ophthalmol, 2017, 10(3): 391-399.
[44]
Sisk RA, Berrocal AM, Feuer WJ, et al. Visual and anatomic outcomes with or without surgery in persistent fetal vasculature[J]. Ophthalmology, 2010, 117(11): 2178-2183.
[45]
Tereshchenko AV, Trifanenkova IG, Vladimirovich VM. Femto-second laser-assisted anterior and posterior capsulotomies in children with persistent hyperplastic primary vitreous[J]. J Cataract Refract Surg, 2020, 46(4): 497-502.
[46]
Bata BM, Chiu HH, Mireskandari K, et al. Long-term visual and anatomic outcomes following early surgery for persistent fetal vasculature: a single-center, 20-year review[J]. J AAPOS, 2019, 23(6): 327.
[47]
Frezzotti R, Bardelli AM, Morocutti A, et al. The pars plana approach in two cases of persistent hyperplastic primary vitreous (PHPV) [J]. Ophthalmic Paediatr Genet, 1984, 4(2): 107-110.
[48]
Khurana S, Ram J, Singh R, et al. Surgical outcomes of cataract surgery in anterior and combined persistent fetal vasculature using a novel surgical technique: a single center, prospective study[J]. Graefes Arch Clin Exp Ophthalmol, 2021, 259(1): 213-221.
[49]
Zahavi A, Weinberger D, Snir M, et al. Management of severe persistent fetal vasculature: case series and review of the literature[J]. Int Ophthalmol, 2019, 39(3): 579-587.
[1] 庞嘉越成, 巨淑慧, 马冀青, 李恒宇, 盛湲. 乳腺癌易感基因突变人群接受降低乳腺癌风险手术的研究进展[J]. 中华乳腺病杂志(电子版), 2023, 17(03): 179-183.
[2] 古丽米拉·亚森江, 阿依努尔·艾尔肯, 李佳隆, 郭强, 蒋铁民, 吐尔干艾力·阿吉. 胆囊切除术后胆管损伤不同治疗方式的疗效分析[J]. 中华普通外科学文献(电子版), 2023, 17(04): 262-266.
[3] 张明, 谭钦元, 杨为杰, 王晓庆. 膀胱鳞状细胞癌的诊治进展[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(01): 90-92.
[4] 张晓贝, 曹栋, 杨宝顺, 俞永江. 肝硬化腹水合并腹股沟疝的临床治疗进展[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(02): 121-124.
[5] 赵佳音, 张晓萌, 张艳, 李立, 王瑞灯. 创伤后肘关节僵硬的病理机制及治疗进展[J]. 中华肩肘外科电子杂志, 2023, 11(02): 181-185.
[6] 张涛, 崔进, 周启荣, 陈晓, 苏佳灿. 肩锁关节脱位的治疗进展[J]. 中华肩肘外科电子杂志, 2023, 11(01): 77-82.
[7] 郝壮, 马济远, 何梦梅, 李兴育, 陆新婷, 武静, 周健. 迟发性囊袋阻滞综合征临床特征、治疗方法及其疗效的临床研究[J]. 中华眼科医学杂志(电子版), 2023, 13(02): 70-75.
[8] 钟东. 大脑凸面脑膜瘤的个体化全程管理[J]. 中华神经创伤外科电子杂志, 2023, 09(04): 193-198.
[9] 廖环, 徐蛟天, 张海涛, 邱光庭, 蒋成昊, 陈进, 邹景芳, 张志文. 颈椎管内外节细胞神经瘤一例报道及文献复习[J]. 中华神经创伤外科电子杂志, 2023, 09(03): 186-189.
[10] 朱敏, 李法强. CD64指数联合降钙素原、白介素-6、血清淀粉样蛋白A检测对重型颅脑损伤术后颅内细菌感染的诊断价值[J]. 中华神经创伤外科电子杂志, 2023, 09(01): 26-31.
[11] 刘家伦, 郑占乐. 跟骨载距突解剖与临床应用现状[J]. 中华老年骨科与康复电子杂志, 2023, 09(03): 188-192.
[12] 马四海, 杨剑, 马显武, 张敏, 吕明礼, 李启菊, 杨轶声, 刘海生. Shamblin Ⅱ型颈动脉体瘤的诊疗及文献综述[J]. 中华临床医师杂志(电子版), 2023, 17(04): 467-470.
[13] 关振鹏. 立足阶梯化手术治疗理念,助力膝骨关节炎外科管理[J]. 中华临床医师杂志(电子版), 2022, 16(10): 919-924.
[14] 江凯乐, 杨异. 肋骨骨折的手术治疗进展及存在问题[J]. 中华胸部外科电子杂志, 2023, 10(03): 149-152.
[15] 王新桥, 马超英, 张旭光. 纵隔单中心型Castleman病诊治体会及文献复习[J]. 中华胸部外科电子杂志, 2023, 10(03): 183-187.
阅读次数
全文


摘要